NEW DELHI
Patient groups, healthcare providers, and manufacturers associations have expressed their dismay as the Centre prepares to table the New Drugs, Cosmetics and Medical Device Bill, 2023 in Parliament, without adequately addressing their concerns, the concerned groups said in a statement issued on December 16.
While the proposed legislation is aimed at regulating the medical device sector, industry leaders argue that key issues such as regulatory complexities, the potential impact on innovation, and the need for a conducive business environment have yet to be adequately assured by redressal in the proposed Bill.